IBS Publications Repository: Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy

BROWSE

Related Scientist

rna's photo.

rna: rna연구단

ITEM VIEW & DOWNLOAD

IBS Publications RepositoryCenter for RNA Research(RNA 연구단)1. Journal Papers (저널논문)

Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy

DC Field	Value	Language
dc.contributor.author	Seonghun Kang	-
dc.contributor.author	Yu Lim Hong	-
dc.contributor.author	Bon-Cheol Ku	-
dc.contributor.author	Seunghyun Lee	-
dc.contributor.author	Seomgwoo Ryu	-
dc.contributor.author	Dal-hee Min	-
dc.contributor.author	Hongje Jang	-
dc.contributor.author	Young-kwan Kim	-
dc.date.available	2019-01-03T05:30:44Z	-
dc.date.created	2018-10-15	-
dc.date.issued	2018-11	-
dc.identifier.issn	0957-4484	-
dc.identifier.uri	https://pr.ibs.re.kr/handle/8788114/5070	-
dc.description.abstract	A therapeutic reduced graphene oxide (RGO) is synthesized by using fucoidan (Fu) as the reducing and surface functionalizing agent. The synthesized Fu-RGO exhibits promising characteristics for therapeutic applications such as high dispersity in aqueous media, biocompatibility, selective cytotoxicity to cancer cells, high loading capacity of the anticancer drug, and photothermal conversion effect. Therefore, Fu-GO is successfully harnessed as a combinatorial cancer treatment platform through bio-functional (Fu), chemo (doxorubicin (Dox)) and photothermal (RGO with near-infrared irradiation) modalities. © 2018 IOP Publishing Ltd Printed in the UK	-
dc.description.uri	1	-
dc.language	영어	-
dc.publisher	IOP PUBLISHING LTD	-
dc.subject	fucoidan	-
dc.subject	graphene oxide	-
dc.subject	reduction	-
dc.subject	surface functionalization	-
dc.subject	cancer therapy	-
dc.title	Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy	-
dc.type	Article	-
dc.type.rims	ART	-
dc.identifier.wosid	000445953400002	-
dc.identifier.scopusid	2-s2.0-85054534896	-
dc.identifier.rimsid	65710	-
dc.contributor.affiliatedAuthor	Dal-hee Min	-
dc.identifier.doi	10.1088/1361-6528/aadfa5	-
dc.identifier.bibliographicCitation	NANOTECHNOLOGY, v.29, no.47, pp.475604	-
dc.citation.title	NANOTECHNOLOGY	-
dc.citation.volume	29	-
dc.citation.number	47	-
dc.citation.startPage	475604	-
dc.embargo.liftdate	9999-12-31	-
dc.embargo.terms	9999-12-31	-
dc.description.journalClass	1	-
dc.description.journalRegisteredClass	scie	-
dc.description.journalRegisteredClass	scopus	-
dc.subject.keywordPlus	DRUG-DELIVERY	-
dc.subject.keywordPlus	GOLD NANOPARTICLES	-
dc.subject.keywordPlus	CELLS	-
dc.subject.keywordPlus	REDUCTION	-
dc.subject.keywordPlus	ANTICOAGULANT	-
dc.subject.keywordPlus	INDUCTION	-
dc.subject.keywordPlus	APOPTOSIS	-
dc.subject.keywordPlus	MOLECULE	-
dc.subject.keywordAuthor	fucoidan	-
dc.subject.keywordAuthor	graphene oxide	-
dc.subject.keywordAuthor	reduction	-
dc.subject.keywordAuthor	surface functionalization	-
dc.subject.keywordAuthor	cancer therapy	-